EXECUTIVE SUMMARY: The report basically highlights on how the pharmaceutical industry of India

There were two pharmaceutical companies that were looking for ways to expand globally to position themselves in a competitive advantage from their competitors. One was located in the United States, which was Eli Lilly and

They are in partnership with Aspen Dental Management Inc. which provides non-clinical business support services to them and their customers. They are also in partnership with leading oral health product manufacturer such as Procter & Gamble which provides most of their supply needs (Aspen Dental, 2016). Their distribution strategy is clearly exclusive in nature. This is so because the dentures service they provided requires a high level of technical and medical knowledge and it’s all done in their on-site denture laboratory thereby excluding any intermediaries.

Economic: Globalization of the pharmaceutical industry is an exciting opportunity to have research and development done at cheaper prices in other countries. However, this could be a double edged sword for companies because it is easy for other countries, such as India, to produce generic versions of the drug in bulk.

This section we are analyzing the Indian Pharmacy at which the Ajanta Pharma belongs and the overall external environment in which the company is operating.

Five of the top ten pharmaceutical companies are located in the United States and the other five are European companies, all of these companies combined, employ approximately 787,000 people. The ranking of the following pharmaceutical companies are based on

The pharmaceutical industry continues to be a major driver of trend. While demand for medicine rapidly increases in emerging economies, a growing number of consumers are also analyzing the economic performance of different medicines. These events will heighten the challenges the

Founded in 1876, Eli Lilly is a pharmaceutical company that completes nearly every step of the product supply chain internally. The company researches, develops, produces and sells a large variety of agricultural products as well as human healthcare items. Over the past century, Eli Lilly has risen to become one of the largest and most successful pharma companies in the USA. In 1992, the year of Eli Lilly-Ranbaxy Private Limited joint venture (ELR), the company’s products were produced in 25 countries and sales spanned over 130 countries. This successful international integration gave Eli Lilly encouragement to continue their globalization strategy in India through a Joint Venture (JV) with Ranbaxy Laboratories, a

The company’s roots go all the way back to 1973 and the company has since grown to have pharmacies around the UK, but also elsewhere in Europe and even Brazil. It has won a number of awards in recent years.

The company mission statement indicates that it envisions becoming a principal pharmaceutical manufacturing corporation with a special dedication to advance innovation in medicine with the

There are advantages of starting a pharmaceutical firm in India. It has emerged from being an enzyme-producing firm to a biotech powerhouse under the guidance of Ms Kiran M. Shaw. They have a well-established pharmaceutical industry that has been growing since 1947. After the purchase of Hindustan Antibiotics Ltd. and India Drug and Pharmaceuticals Ltd. they were able to compete with the MNC’s (Multi National Corporaton) from overseas (Kalegaonkar, Locke, Lehrich, 2008, p. 2). In the beginning the pharmaceutical industry saw substantial growth. “By the beginning of the 21st century, over 20,000 pharmaceutical companies were operating in India” (Kalegaonkar, Locke, Lehrich, 2008, p. 2). “The pharmaceutical industry in India is ranked third

has been a dominate force in the pharmaceutical manufacturing industry in the United States. The company has a “preliminary unaudited cash and cash equivalents as of December 31, 2014 were approximately $42.2 million. This includes $21.5 million in cash from the term loan and revolving line of credit secured in December 2014. An additional $8.5 million is being held in escrow from the proceeds of the sale of Sumavel DosePro to Endo Pharmaceuticals in May 2014” (New York Times, 2015). They have made some acquisitions of companies that includes Brabant Pharma. They have also increased their total prescriptions by 26% in the fourth quarter of 2014, compared to the third quarter. Information for the first quarter of 2015 is not yet available so was not able to determine if they are still increasing. The company’s mission statement as stated previously is “company that is committed to developing therapies that address specific clinical needs for people living with CNS and pain-related conditions who need innovative treatment alternatives to help them return to normal daily functioning” and it is actually their mission statement (About Us). I believe the overall objective of this company to manufacture products that target specific illnesses that are found in the US such as CNS illnesses, chronic pain that is not alleviated by medications on the market now and they are in the clinical trials of a product they are developing for people with schizophrenia. It

By 2004, its product pipeline focused on viral infections, inflammatory and autoimmune disorders, and cancer. It maintains headquarters in South Boston, Massachusetts, and two research facilities, in San Diego, California, and Oxford, England. The company's beginnings were profiled by Barry Werth in the 1994 book The Billion-Dollar

We analyzed the Indian Pharmaceutical industry on these five forces and the findings of industry competitiveness and profitability are written under the relevant competitive forces.

Today, it provides a full marketplace to the online customers. The company boasts of more than 80 million registered users. Estimates suggest that the company receives more than 60 million orders per month. It is headquartered in Noida, India.

This report provides an analytical strategic review of the global pharmaceutical industry; its origin, evolution,